Patents by Inventor Alex Michael Jelenevsky

Alex Michael Jelenevsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bicyclo [2.2.1]-heptane-2,3-di-endo-carboxylic acid imide esters
    Patent number: 4122273
    Abstract: A series of 5-endo-(quinoxaline-carbonyloxy)-N[amino-(lower)alkyl]bicyclo[2.2.1]-hepta ne-2,3-di-endo-carboxylic acid imides has been found to possess excellent prophylactic and therapeutic activity as anti-arrhythmic agents.
    Type: Grant
    Filed: February 13, 1978
    Date of Patent: October 24, 1978
    Assignee: Bristol-Myers Company
    Inventors: Ronald Leslie Buchanan, John Theodore Woolever, Alex Michael Jelenevsky
  • Anti-arrhythmic agents
    Patent number: 4018767
    Abstract: A series of 5-endo-(1-naphthoyloxy)-N-[amino-(lower)alkyl]bicyclo[2.2.1]heptane-2,3-di -endo-carboxylic acid imides have been found to possess unique prophylactic and therapeutic activity as anti-arrhythmia agents. An example of such a compound possessing excellent activity is 5-endo-(1-naphthoyloxy)-N-(3-dimethylaminopropyl)bicyclo[2.2.1]heptane-2,3 -di-endo-carboxylic acid imide hydrochloride.
    Type: Grant
    Filed: May 22, 1975
    Date of Patent: April 19, 1977
    Assignee: Bristol-Myers Company
    Inventors: Joseph Paul Buyniski, Alex Michael Jelenevsky, Ronald Leslie Buchanan
  • Anti-arrhythmic 5-endo-substituted oxy-N-(aminoloweralkyl)bicycle [2.2.2.]o c
    Patent number: 3980667
    Abstract: Series of 5-endo-benzoyloxy-N-[amino(lower)-alkyl]bicyclo[2.2.2]octane-2,3-di-endo-c arboxylic acid imides, 5-endo-(3-indolecarbonyloxy)-N-[amino-(lower)alkyl]bicyclo[2.2.2]octane-2, 3-di-endo-carboxylic acid imides, 5-endo-n-substituted-carbamoyloxy-N-[amino(lower)alkyl]bicyclo[2.2.2]octan e-2,3-di-endo-carboxylic acid imides and 5-endo-(1-naphthoyloxy)-N-[amino(lower)alkyl]bicyclo[2.2.2]octane-2,3-di-e ndo-carboxylic acid imides have been found to possess unique prophylactic and therapeutic activity as anti-arrhythmia agents. An example of such a compound possessing activity is 5-endo-(3-indolecarbonyloxy)-N-(3-dimethylaminopropyl)bicyclo[2.2.
    Type: Grant
    Filed: March 5, 1975
    Date of Patent: September 14, 1976
    Assignee: Bristol-Myers Company
    Inventors: Richard Anthony Partyka, Henry Michael Holava, Alex Michael Jelenevsky
  • Anti-arrhythimic 5-endo-(3-indolecarbonyloxy)-N-[amino-(lower)alkyl]bicyclo[2,2,1]heptane -2,3-di-endo-carboxylic acid imides
    Patent number: 3980668
    Abstract: A series of 5-endo-(3-indolecarbonyloxy)-N-[amino-(lower)alkyl]bicyclo[2.2.1]heptane-2 ,3-di-endo-carboxylic acid imides having the formula ##SPC1##Wherein R.sup.1 is H, Cl, Br, F or (lower)alkyl, R.sup.7 is H or methyl, R.sup.2 and R.sup.3 are alike or different and each is H, Cl, Br, F, (lower)alkyl, nitro, CF.sub.3, OH or (lower)alkoxy, n is an integer of 2 to 4 inclusive and R.sup.4 and R.sup.5 are alike or different and each is H, (lower)alkyl or when taken together with the nitrogen a radical of the formula ##SPC2##In which R.sup.6 is (lower)alkyl; or a pharmaceutically acceptable acid addition salt thereof have been found to possess unique prophylactic and therapeutic activity as anti-arrhythmia agents. An example of such a compound possessing excellent activity is 5-endo-(3-indolecarbonyloxy)-N-(3-dimethylaminopropyl)bicyclo-[2.2.1]hepta ne-2,3-di-endo-carboxylic acid imide hydrochloride.
    Type: Grant
    Filed: July 10, 1975
    Date of Patent: September 14, 1976
    Assignee: Bristol-Myers Company
    Inventors: Ronald Leslie Buchanan, Alex Michael Jelenevsky